AI application startup Mycelebs raises funding to provide AI solutions to more enterprises

Mycelebs, an AI application group, announced that they received a secret amount of funding from DSC Investment and individuals at Shinhan Investment Corp, Samsung, SKT, and Google.

Mycelebs utilizes various AI technologies and provides solutions for other business items.

Mycelebs developed an operation tool for data collection, investigation, visualization, AI loading, and automatic performance, called Big Data Studio. Based on this tool, Mycelebs collaborates with large Korean companies in different fields and upgrades their existing service to AI driven service and a new solution with features like preference search, live website, chat bot, and VUX.

Estelle Shin, CEO of Mycelebs, stated that “AI application developed by Mycelebs is highly competitive, such that it will generate outstanding revenue through real business. We are prepared to extend our business after obtaining enough funding.”

DSC Investment revealed the main reason of the investment and said “Mycelebs possesses qualified references through its work with leading companies in many industries based on high technology. Therefore, utilisation of the business is exceedingly high.”

(Top photo from 699pic.com)


This article, entitled “AI application startup Mycelebs raises funding to provide AI solutions to more enterprises”, was written in Korean by Platum, edited by AllTechAsia.

AllTechKorea Staff
AllTechKorea Staff

AllTechKorea is a news channel of AllTechAsia, focusing on South Korea's tech industry. News on this channel is produced in collaboration with Platum, the leading tech news platform in South Korea. Write to us: atk[at]alltechasia.com.

No Comments Yet

Comments are closed

 

© 2019 All Tech Asia. All Rights Reserved.

AllTechAsia is a startup media platform dedicated to providing the hottest news, data service and analysis on the tech and startup scene of Asian markets in English.
Contact us: info@alltechasia.com

About Us

FOLLOW US ON

Subscribe to Our Newsletter